Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Autor: Tiong IS; The Alfred Hospital and Monash University, Melbourne, Australia.; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia., Hiwase DK; Royal Adelaide Hospital, Adelaide, Australia.; University of Adelaide, Adelaide, Australia.; South Australian Health and Medical Research Institute, Adelaide, Australia., Abro E; Princess Alexandra Hospital, Queensland, Australia., Bajel A; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia., Palfreyman E; Royal Darwin Hospital, Northern Territory, Australia., Beligaswatte A; University of Adelaide, Adelaide, Australia.; Flinders Medical Centre, Bedford Park, Australia., Reynolds J; The Alfred Hospital and Monash University, Melbourne, Australia., Anstee N; The University of Melbourne, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Nguyen T; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia., Loo S; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; The Northern Hospital, Melbourne, Australia., Chua CC; The Alfred Hospital and Monash University, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; The Northern Hospital, Melbourne, Australia., Ashby M; The Alfred Hospital and Monash University, Melbourne, Australia., Wiltshire KM; The Alfred Hospital and Monash University, Melbourne, Australia., Fleming S; The Alfred Hospital and Monash University, Melbourne, Australia., Fong CY; Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia., Teh TC; The Alfred Hospital and Monash University, Melbourne, Australia.; Box Hill Hospital, Melbourne, Australia., Blombery P; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Dillon R; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.; Guy's Hospital, London, United Kingdom., Ivey A; The Alfred Hospital and Monash University, Melbourne, Australia., Wei AH; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 20; Vol. 42 (18), pp. 2161-2173. Date of Electronic Publication: 2024 Mar 01.

Asphyxiation causing distinctive basal ganglia injury and generalized dystonia.

Autor: Wiltshire KM; Faculty of Medicine, University of Calgary, Alberta, Canada., Myers K, Wei XC, Mohamed I

Publikováno v: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [Can J Neurol Sci] 2011 May; Vol. 38 (3), pp. 514-5.